4.5 Review

Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality

Journal

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
Volume 95, Issue 7, Pages 936-939

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/09553002.2019.1623429

Keywords

Radiation therapy; immunotherapy; immune checkpoint blockade; checkpoint inhibitors; CTLA-4; metastatic disease; abscopal effect; stereotactic radiation therapy

Funding

  1. Bristol-Myers Squibb
  2. Eisai
  3. Janssen
  4. Merck
  5. Regeneron
  6. Varian

Ask authors/readers for more resources

Purpose: The aim of this review is to highlight key evidence supporting the effect of radiation therapy on tumor immunity. Conclusions: Recent findings in both the preclinical and clinical settings have provided convincing evidence of the ability of radiation therapy to influence tumor-directed immune responses, and have offered critical insights into the underlying mechanisms. Not only does radiation therapy convert the tumor microenvironment to promote robust tumor immunity, but it also enhances the generation of neoantigens and neoepitopes. Radiation therapy also shapes the TCR repertoire of CD8(+) T cells in conjunction with immune checkpoint blockade. In conclusion, a high priority should be placed on developing rational strategies to integrate radiation therapy with immunotherapy in the clinical setting, with an emphasis on careful patient selection and identifying important correlative endpoints.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available